Freudenberg Medical has launched several new hemostasis valves for interventional and diagnostic catheters.
HyperSeal and CertuSeal hemostasis valves have been added to the FlexSeal valve line that the company released last year. Freudenberg Medical also added its new HyperSeal Introducer Sheath with Hydrophilic Coating to the FlexSeal Introducer Sheath for large bore procedures.
The catheters were introduced at the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Denver this year.
“Freudenberg Medical’s hemostasis valves provide a wide range of innovative features designed to greatly improve hemostasis and procedural performance when integrated into next-generation catheters and delivery systems,” Bernie Kaeferlein, director of portfolio management at Freudenberg Medical. “As a partner for innovation, we are committed to proactively addressing unmet clinical needs and offering our medical device customers a growing portfolio of finished device, design and process solutions to help improve efficiency and accelerate their time to market.”
(Network with Freudenberg Medical experts at DeviceTalks West, Dec. 11–12 in Orange County, Calif.)
![An illustration showing the Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system's valve being placed in the heart. [Image courtesy of Edwards Lifesciences]](https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2025/04/Edwards-Lifesciences-Sapien-M3-TMVR-valve-delivery-268x170.jpg)